Alan Louis Urban - 17 Oct 2024 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Chief Financial Officer
Signature
/s/ Alan Urban
Issuer symbol
GTBP
Transactions as of
17 Oct 2024
Net transactions value
$0
Form type
4
Filing time
21 Oct 2024, 21:13:40 UTC
Previous filing
13 Jun 2024
Next filing
08 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +23,335 $0.000000 23,335 17 Oct 2024 Common Stock 23,335 $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares vest on the monthly anniversary of June 3, 2024 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant without Cause (as defined in the reporting person's Employment Agreement dated June 7, 2024), resignation by the reporting person for Good Reason (as defined in the reporting person's Employment Agreement dated June 7, 2024), or in the event of a Change in Control (as defined in the registrant's 2022 Omnibus Incentive Plan).